Emma Wilkinson is a freelance journalist specialising in biosciences, medicine and health policy. She started out at The Lancet, before moving to Pulse to work as a clinical reporter where she won several awards. Other staff positions include four years as a health reporter at BBC News online. She has also worked for Nursing Times, the European Heart Journal, Chemist and Druggist, OTC, and Pregnancy and Birth magazine among others. Emma now splits her time between writing, editing and teaching at both Sheffield Hallam University and the University of Sheffield where she helped develop the MSc in Science Communication.
A major initiative by pharmacists to reduce risky medicines use in the community will be rolled out across the country after it was found to reduce serious adverse events.
The 2018 Supreme Court verdict on Pfizer’s second patent for Lyrica has drawn attention to the limitations of the current framework for extending the usefulness of existing treatments.
Lack of time and not being able to access the required information means that many community pharmacists in England are not using abbreviated patient records online.
NHS looks to pharmacy as it faces a tough winterSubscription